BDBM790266 (R)(3S,4S)(3S,4S) or (R)(3S,4S)(3R,4R) or (R)(3R,4R)(3S,4S) or (R)(3R,4R)(3R,4R) or (S)(3S,4S)(3S,4S) or (S)(3S,4S)(3R,4R) or (S)(3R,4R)(3S,4S) or (S)(3R,4R)(3R,4R) N-[5-chloro- 1-(2,2-difluorocyclopropyl)-1H- pyrazol-4-yl]-7-[3-fluoro-1-(4- methoxyoxolan-3-yl)piperidin-4- yl]-6-methylquinazolin-2-amine::US12540131, Ex-4.244

SMILES CO[C@H]1COC[C@H]1N1CC[C@@H](c2cc3nc(Nc4cnn(C5CC5(F)F)c4Cl)ncc3cc2C)[C@H](F)C1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 790266   

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 790266BDBM790266((R)(3S,4S)(3S,4S) or (R)(3S,4S)(3R,4R) or (R)(3R,4...)
Affinity DataIC50: 0.631nMAssay Description:Initial cell-based XBP-1 mRNA splicing assays confirmed IRE-1α inhibition with several potent 5-bromo and 6 bromo o-vanillins. HEK293 cells were...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/15/2026
Entry Details US Patent